Study of Clinical Profile and Microbiology of Community- Acquired Pneumonia

Rushita D. Nakarani *

Department of Pulmonary Medicine, Ruby Hall Clinic, 40, Sasoon Road, Pune, Maharashtra, India.

R.K. Chopra

Department of Pulmonary Medicine, Ruby Hall Clinic, 40, Sasoon Road, Pune, Maharashtra, India.

Rupali Suryawanshi

Department of Microbiology, Ruby Hall Clinic, 40, Sasoon Road, Pune, Maharashtra, India.

*Author to whom correspondence should be addressed.


Abstract

Aim: This study aimed to investigate the patterns of etiological agents, predisposing factors, radiological presentations, and bacteriological etiologies of Community- Acquired Pneumonia (CAP). The primary objective was to study the prevalence of CAP, while the secondary objective was to explore its association with age, sex, comorbidities, risk factors and causative organisms.

Study Design: Prospective observational study.

Place and Duration of Study: The study was conducted at Ruby Hall Clinic, Pune, from December 1, 2022, to November 30, 2023.

Background: Community-acquired pneumonia (CAP) Considered as one of the main causes of morbidity and mortality, particularly in the elderly. Diagnosis relies on clinical, radiological, and microbiological assessments. The study aims to provide insight into the clinical and microbiological profiles of CAP in a developing country setting.

Methodology: 72 patients aged over 12 years, presenting with clinical and radiological evidence of CAP, were enrolled. Standard investigations included complete blood count, biochemistry, sputum Gram stain and culture, blood culture, BioFire FilmArray Pneumonia Panel, chest X-ray, and CT scan. The BioFire Panel was used selectively due to cost considerations. Data analysis employed statistical methods such as the Chi-Square test, Mean, Standard Deviation, Fischer Exact test, and Odds Ratio.

Results: The mean age of the patients was 59.93 years, with a male predominance (61%). Fever, dyspnea, and cough were the predominant symptoms. Common comorbidities included hypertension, diabetes, and chronic lung diseases. Microbiological analysis revealed diverse pathogens, with gram-positive cocci in 17% and gram-negative bacilli in 11% of cases. Sputum culture and BioFire Panel identified various bacterial and viral pathogens. Prior antibiotic use significantly affected sputum culture results but not BioFire test outcomes.

Conclusion: CAP in the studied cohort presented with diverse clinical and microbiological profiles. The BioFire Panel demonstrated higher sensitivity and a broader pathogen detection range compared to conventional methods. The findings emphasize the need for precise diagnostic tools and tailored treatment strategies to manage CAP effectively.

Keywords: Community-Acquired Pneumonia (CAP), microbiologic tests, bio fire film array pneumonia panel


How to Cite

Nakarani , Rushita D., R.K. Chopra, and Rupali Suryawanshi. 2024. “Study of Clinical Profile and Microbiology of Community- Acquired Pneumonia”. Journal of Advances in Medicine and Medical Research 36 (7):86-103. https://doi.org/10.9734/jammr/2024/v36i75488.

Downloads

Download data is not yet available.

References

Community-acquired pneumonia - Pulmonary disorders - MSD manual professional edition. Available:https://www.msdmanuals.com/enin/professional/pulmonarydisorders/pneumonia/community-acquired-pneumonia

[Accessed On:2023 Apr 4].

García-Vázquez E, Marcos MA, Mensa J. Assessment of the usefulness of sputum culture for diagnosis of community-acquired pneumonia using the port predictive scoring system. Arch Intern Med. 2004;164(16):1807–1811. DOI: 10.1001/archinte.164.16.1807

Manatrey-Lancaster JJ, Bushman AM, Caligiuri ME, Rosa R. Impact of BioFire FilmArray respiratory panel results on antibiotic days of therapy in different clinical settings. Antimicrobial Stewardship & Healthcare Epidemiology. Cambridge University Press. 2021;1(1):e4.

Burk M, El-Kersh K, Saad M, Wiemken T, Ramirez J, Cavallazzi R. Viral infection in community-acquired pneumonia: A systematic review and meta-analysis.Available:http://ow.ly/X03pK

[Accessed On:2023 Oct 28];

Cillóniz C, Cardozo C, García-Vidal C. Epidemiology, pathophysiology, and microbiology of community-acquired pneumonia. Ann Res Hosp. 2018;2(1):1–1.

[Accessed On:2023 May 13]Available:https://arh.amegroups.com/article/view/3921/html

Metlay JP, Waterer GW, Long AC. Diagnosis and treatment of adults with community-acquired pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019; 200:e45.

Holm A, Nexoe J, Bistrup LA. Aetiology and prediction of pneumonia in lower respiratory tract infection in primary care. Br J Gen Pract. 2007; 57:547.

White RJ, Blainey AD, Harrison KJ, Clarke SK. Causes of pneumonia presenting to a district general hospital. Thorax. 1981;36 (8):566-70.

Torres A, Serra-Batlles J, Ferrer A, Jimenez P, Celis R, Cobo E. Severe community-acquired pneumonia. Epidemiology and prognostic factors. Am Rev Respir Dis. 1991;144(2):312–8.

[Accessed On:2023 Mar 24] Available:https://pubmed.ncbi.nlm.nih.gov/1859053/

Oberoi A, Aggarwal A. Bacteriological Profile, Serology and Antibiotic Sensitivity Pattern of Micro-organisms from Community-Acquired Pneumonia.

Shah BA, Singh G, Naik MA, Dhobi GN. Bacteriological and clinical profile of Community-acquired pneumonia in hospitalized patients. Lung India. 2010;27(2):54–7.

[Accessed On:2023 Apr 4] Available:https://pubmed.ncbi.nlm.nih.gov/20616935/

Assefa M. Multi-drug resistant gram-negative bacterial pneumonia: aetiology, risk factors, and drug resistance patterns. Pneumonia.2022;14(1):1–12.

Accessed On:2023 Dec 5] Available:https://pneumonia.biomedcentral.com/articles/10.1186/s41479-022-00096-z

Cillóniz C, Dominedò C, Torres A. Multidrug-Resistant Gram-Negative Bacteria in Community-Acquired Pneumonia. Crit Care. 2019;23(1):1–9. [Accessed on:2023 Dec 5] Available:https://ccforum.biomedcentral.com/articles/10.1186/s13054-019-2371-3

Arancibia F, Bauer TT, Ewig S, Mensa J, Gonzalez J, Niederman MS. Community-Acquired Pneumonia Due to Gram-Negative Bacteria and Pseudomonas aeruginosa: Incidence, Risk, and Prognosis. Arch Intern Med. 2000;162 (16):1849–58.

Available:https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/212617

[Accessed On:2023 Dec5]

Risk factors and prevention of hospital-acquired and ventilator-associated pneumonia iadults UpTo Date

[Accessed On: 2023 Mar 25].Available:https://sso.uptodate.com/contents/risk-factors-and-prevention-of-hospital-acquired- and-ventilator-associated-pneumonia-in-adults?source=related_link

Inamdar DP, Anuradha B, Inamdar P, Patti PS. Microbiota of bronchoalveolar lavage samples from patients of lower respiratory tract infection - A changing trend. J Pure Appl Microbiol. 2021;15(3):1508–16.

Overview of community-acquired pneumonia in adults – UpToDate. [Accessed On:2023 Nov 5]. Available:https://www.uptodate.com/contents/overview-of- community-acquired-pneumonia-in-adults/print?search=defination%20of%20CAP&source=search_result&selectedTitle= 1~150&usage_type=default&display_rank=1

The BioFire® FilmArray® Pneumonia Panel | BioFire Diagnostics.

[Accessed On:2023 Nov 5]. Available:https://www.biofiredx.com/products/the-filmarraypanels/filmarraypneumonia/

Kumar RG, Professor A. Clinical profile and prognosis of community-acquired pneumonia. Int J Cur Res Rev; 2021

[Accessed On:2023 Jul 29];13. Available:http://dx.doi.org/10.31782/IJCRR.2021.131425

Mandell LA, Marrie TJ, Grossman RF, Chow AW, Hyland RH. Canadian guidelines for the initial management of community-acquired pneumonia: An evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. Clin Infect Dis. 2000; ;31(2):383–421.

[Accessed On: 2023 May 22]. Available:https://pubmed.ncbi.nlm.nih.gov/10987698/

Thomas M. File Jr, Ramirez JA. Community-Acquired Pneumonia. O’Malley PG, editor. Available:https://doi.org/101056/NEJMcp2303286

;389(7):632–41.

[Accessed On:2023 Oct 28]Available:https://www.nejm.org/doi/pdf/10.1056/NEJMcp2303286

The BioFire® FilmArray® Pneumonia Panel | BioFire Diagnostics.

[Accessed on;2023 Dec 7]. Available:https://www.biofiredx.com/products/the-filmarray-panels/filmarraypneumonia/

Kabeerdoss J, Sankaran V, Pugazhendhi S, Ramakrishna BS. Clostridium leptum group bacteria abundance and diversity in the faecal microbiota of patients with inflammatory bowel disease: a case–control study in India. BMC Gastroenterology. 2013;13(1):1-8.

Macfarlane J. Community-acquired pneumonia. British Journal of Diseases of the Chest. 1987;81:116-27. .

Pachon J, Prados MD, Capote F, Cuello JA, Garnacho J, Verano A. Severe community-acquired pneumonia. Am Rev Respir Dis. 1990;142:369-73. .

Marrie TJ, Durant H, Yates L. Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Reviews of infectious diseases. 1989;11 (4):586-99.

Costa MI, Cipriano A, Santos FV., Valdoleiros SR, Furtado I, Machado A, et al. Clinical profile and microbiological aetiology diagnosis in adult patients hospitalized with community-acquired pneumonia. Pulmonology. 2022;28(5):358–67.

Jain. Study of Clinical, Radiological, and bacteriological profile of community- acquired pneumonia in hospitalized patients. Available:http://www.ijsssn.com/uploads/2/0/1/5/20153321/ijss_sep_oa22.pdf.

Antela A, Guerrero A, Meseguer M, González-Sainz J, Escudero R, Pérez Elías MJ, Quereda C, Hermida JM, Cobo J, Montilla P. Community-acquired pneumonia: A prospective study of 101 adult, immunocompetent patients for 1 year. Enfermedades Infecciosas Y Microbiologia Clinica. 1993;11(10):525-30.

Pneumonia in right lower Lobe: Symptoms, causes, and treatment | nao medical.

[Accessed on:2023 Dec 7].Available:https://naomedical.com/blog/pneumonia- right-lower-lobe-nao-medical

Bansal S, Kashyap S, Pal LS, Goel A. Clinical and bacteriological profile of community- acquired pneumonia in Shimla, Himachal Pradesh. Indian J Chest Dis Allied Sci. 2004;46:17-22.

Culture and Sensitivity, (C and S, C/S), and Antibiotics.

[Accessed On:2023 Oct 28]. Available: https://labpedia.net/culture-and-sensitivity-c-and-s-c-s-and-antibiotics/

Kosai K, Akamatsu N, Ota K, Mitsumoto-Kaseida F, Sakamoto K, Hasegawa H. BioFire film array pneumonia panel enhances the detection of pathogens and antimicrobial resistance in lower respiratory tract specimens. Ann Clin Microbiol Antimicrob; 2022.

[Accessed on:2023 Dec 7];21(1). Available:https://pubmed.ncbi.nlm.nih.gov/35659683/

Endicott-Yazdani TR, Baylor; TP093 new developments in diagnostics and treatments of pneumonia / thematic poster session concordance of biofire pneumonia panel with traditional respiratory bacterial culture results.

[Accessed on:2023 Dec 7]Available from: www.atsjournals.org

Kosai, K., Akamatsu, N., Ota, K. et al. BioFire FilmArray Pneumonia Panel enhances the detection of pathogens and antimicrobial resistance in lower respiratory tract specimens. Ann Clin Microbiol Antimicrob. 2022;21:24.Available:https://doi.org/10.1186/s12941-022-00512-8.

Roth K, Roth SKM. Chief bacterial multiplex and medical counter measures branch division of microbiology devices OHT7: Office of In vitro diagnostics and radiological health office of product evaluation and quality center for devices and radiological health enclosure.

[Accessed On:2023 Oct 28]Available: https://www.fda.gov/medical-

Mahmoud NE, Altayb HN, Gurashi RM. Detection of carbapenem-resistant genes in Escherichia coli isolated from drinking Water in Khartoum, Sudan. J Environ Public Health. 2020;2020.

Waterer GW, Kessler LA, Wunderink RG. Delayed administration of antibiotics and atypical presentation in community-acquired pneumonia. Chest 2006 ;130:11.